the evolving landscape of all therapy and the impact of mrd
Published 5 years ago • 118 plays • Length 15:02Download video MP4
Download video MP3
Similar videos
-
11:57
the evolving genomic landscape of all: molecular genetics, profiling and classification
-
3:36
the genetic landscape of mds: how this is improving & impacting the development of therapies
-
1:01
recent and future changes in the landscape of aml: the addition of venetoclax and mrd eradication
-
1:23
the evolution of mrd-guided therapy for leukemia
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
2:44
myelofibrosis: jenson shares his experience
-
4:45
day in the life of a doctor: hematology rotation
-
11:19
immunotherapy for aml & all
-
2:30
the importance of mrd-guided therapy in all
-
0:52
evolving landscape of car t-cell therapies
-
1:56
the current landscape of all therapy research
-
1:40
the role of menin inhibitors in the treatment of aml
-
1:15
exploring the evolving treatment landscape of myelofibrosis
-
1:11
the future of myeloma therapy and where the treatment landscape is moving
-
1:29
the current landscape of maintenace therapy in aml and areas for future exploration
-
1:27
maintenance therapy and mrd in myeloma
-
1:05
the importance of using mrd to guide treatment decisions in all
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
2:35
an update on mrd assessment and novel techniques used in the treatment of hematological malignancies
-
1:45
new aims and next steps for adult all induction therapy